- Home
- CATX vs AHRT Comparison
CATX vs AHRT Comparison
Compare CATX & AHRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$4.18
Company Overview
Basic Information| Metric | CATX | AHRT |
|---|---|---|
| Founded | 1983 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 569.6M | 498.7M |
| IPO Year | 2018 | 2013 |
Fundamental Metrics
Financial Performance| Metric | CATX | AHRT |
|---|---|---|
| Price | $4.18 | $5.34 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 1 |
| Target Price | ★ $12.11 | $7.00 |
| AVG Volume (30 Days) | 1.4M | ★ 1.9M |
| Earning Date | 03-16-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 10.20% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $12.71 | $840.79 |
| Revenue Next Year | N/A | $10.97 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.60 | $5.45 |
| 52 Week High | $6.16 | $6.11 |
Technical Indicators
Market Signals| Indicator | CATX | AHRT |
|---|---|---|
| Relative Strength Index (RSI) | 39.69 | 31.98 |
| Support Level | $3.24 | N/A |
| Resistance Level | $4.54 | $5.85 |
| Average True Range (ATR) | 0.38 | 0.25 |
| MACD | -0.14 | -0.04 |
| Stochastic Oscillator | 10.28 | 0.00 |
Price Performance
Historical Comparison CATX
AHRT
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.